Bayer's ALYCE: Advancing Drug Development with Data Intelligence

Healthcare and life sciences industries face rapid data growth. ALYCE, Bayer's Advanced Analytics Platform for the Clinical Data Environment, tackles this using offensive and defensive data strategies, robust governance, and a tailored Lakehouse paradigm design. The ALYCE Data Intelligence Platform enables the analysis of large, complex clinical data while adhering to regulations. It employs business intelligence, AI, and machine learning to expedite clinical trial data review, enhancing patient-centric study designs. The platform supports real-time ingestion, structured-, semi-, and unstructured data; it fosters affordable, open collaboration, empowering data-driven decision-making, improved analytics, and collaboration. Attendees will discover how implementing offensive and defensive data strategies on one unique architectural platform design drives our innovation, improves patient outcomes, boosts collaboration in clinical environments, and ultimately saves costs.